Want to join the conversation?
$CRM said that for 2Q17 the company expects revenue to be in the range of about $2.005-2.015Bil, up 23% YoverY. GAAP diluted EPS is expected in the range of $0.03-0.04, while non-GAAP diluted EPS is projected to be $0.24-0.25. On balance sheet deferred revenue growth is expected in the range of 26-28% YoverY.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?